Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesA +0.87%93 PB Ratio is 5.36 as of Jul. 14, 2026, which is 6% below its 10-year median of 5.73. GuruFocus rates A with a GF Score™ of 93/100 and a GF Value™ of $145.87 (Fairly Valued). The stock has 1 warning sign investors should review. Among 196 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 80.1% on this metric.
The historical rank and industry rank for Agilent Technologies's PB Ratio or its related term are showing as below:
A'
s PB Ratio Range Over the Past 10 Years
Min: 3.22 Med: 5.73 Max: 10.98
Current: 5.36
During the past 13 years, Agilent Technologies's highest PB Ratio was 10.98. The lowest was 3.22. And the median was 5.73.
A's PB Ratio is ranked worse than 80.1% of 196
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.99
vs A: 5.36
During the past 12 months, Agilent Technologies's average Book Value Per Share Growth Rate was 16.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Agilent Technologies was 27.40% per year. The lowest was -20.00% per year. And the median was 5.40% per year.
Back to Basics: PB Ratio
Agilent Technologies (NYSE:A) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Agilent Technologies PB Ratio Related Terms
Agilent Technologies PB Ratio Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Agilent Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies PB Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Agilent Technologies (A) has a PB Ratio of 5.36 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 5.73. Over the past decade, Agilent Technologies' PB Ratio has ranged from 3.22 to 10.98. According to the industry distribution chart, Agilent Technologies ranks #157 out of 196 companies in the Medical Diagnostics & Research industry, placing it in the top 80.1%.
Is Agilent Technologies' PB Ratio too high?
Agilent Technologies' current PB Ratio of 5.36 is near median its 10-year median of 5.73. Over the past 10 years, this metric has ranged from a low of 3.22 to a high of 10.98. The Medical Diagnostics & Research industry median PB Ratio is 1.99. Agilent Technologies' value of 5.36 is 169.3% above this industry median. Based on the distribution chart, Agilent Technologies ranks #157 out of 196 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Agilent Technologies has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' PB Ratio compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #157 out of 196 companies for PB Ratio. This places Agilent Technologies in the lower half of its industry. The industry median PB Ratio is 1.99. Agilent Technologies' value of 5.36 is 169.3% above this benchmark. Historically, Agilent Technologies' own PB Ratio has ranged from 3.22 to 10.98 over the past decade. While the company's 10-year median is 5.73 vs. the industry median of 1.99, Agilent Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Diagnostics & Research company?
The median PB Ratio among Medical Diagnostics & Research companies is 1.99, based on 196 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current PB Ratio of 5.36 is 169.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current PB Ratio is 5.36, which is near median its own 10-year median of 5.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (A) is currently considered Fairly Valued. The stock's GF Value™ is $145.87, compared to a current price of $135.20 — trading 7.3% below its estimated fair value. The current PB Ratio is 5.36, which is near median its 10-year median of 5.73 and 169.3% above the Medical Diagnostics & Research industry median of 1.99. Agilent Technologies' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Agilent Technologies (A), the current PB Ratio is 5.36 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of $135.20 is trading 7.3% below its estimated GF Value™ of $145.87.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for A:
PB Ratio: 5.36 (near median its 10-year median of 5.73)
GF Value™: $145.87 vs. price of $135.20 (7.3% below fair value)
Industry Position: 169.3% above the Medical Diagnostics & Research median (#157 of 196)
No single metric tells the full story. See the A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
93GF Score
Get the complete analysis for A
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
A has been successfully added to your 
